910 related articles for article (PubMed ID: 14623950)
21. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
22. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
[TBL] [Abstract][Full Text] [Related]
23. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
24. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
Su Y; Jia RL; Han L; Li ZG
Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
[TBL] [Abstract][Full Text] [Related]
25. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
[TBL] [Abstract][Full Text] [Related]
26. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
29. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Kumar S; Isenberg DA
Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
[TBL] [Abstract][Full Text] [Related]
30. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.
Nagai T; Arinuma Y; Yanagida T; Yamamoto K; Hirohata S
Arthritis Rheum; 2005 Mar; 52(3):847-55. PubMed ID: 15751081
[TBL] [Abstract][Full Text] [Related]
31. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
32. Reduced anti-TNFalpha autoantibody levels coincide with flare in systemic lupus erythematosus.
Sjöwall C; Ernerudh J; Bengtsson AA; Sturfelt G; Skogh T
J Autoimmun; 2004 Jun; 22(4):315-23. PubMed ID: 15120755
[TBL] [Abstract][Full Text] [Related]
33. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
34. Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab')2) system.
Williams RC; Malone CC; Huffman GR; Silvestris F; Croker BP; Ayoub EM; Massengill S
J Rheumatol; 1995 Jun; 22(6):1075-85. PubMed ID: 7674233
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
Neidhart M
J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
[TBL] [Abstract][Full Text] [Related]
36. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
37. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
38. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
39. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
40. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]